BUY Conviction3/5 Analysis quality75/100 now
The analyst suggests Coloplast is an interesting value due to its significant price drop, currently trading 40% below its all-time high. Despite a recent lowered forecast and increased debt from acquisitions, the company operates in a growing market (medical products for the elderly) with strong customer loyalty and strategic acquisitions aimed at future growth. The stock is currently undervalued based on various metrics, and even with a conservative P/E, it offers an attractive annual return potential.
“Ich halte hier Coloplast erstmal für relativ interessanten Wert, weil die Aktie eben gut nach unten gekommen ist.”